Elixinol Global Ltd

PINK:ELLXF USA Drug Manufacturers - Specialty & Generic
Market Cap
$6.50 Million
Market Cap Rank
#35559 Global
#11587 in USA
Share Price
$0.02
Change (1 day)
+30.83%
52-Week Range
$0.01 - $0.04
All Time High
$4.20
About

Elixinol Wellness Limited, a holding company, provides healthy products in Australia, the Americas, and internationally. The company provides human nutrition, human wellness, pet wellness, and superfood ingredients under Hemp Foods Australia, Mt Elephant, The Healthy Chef, Soul Foods, Ananda Equine, and Field Day brands. It distributed through grocery, wholesale, and e-commerce channels for white… Read more

Elixinol Global Ltd - Asset Resilience Ratio

Latest as of December 2020: 0.20%

Elixinol Global Ltd (ELLXF) has an Asset Resilience Ratio of 0.20% as of December 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
$85.00K
Cash + Short-term Investments
Total Assets
$42.47 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2020)

This chart shows how Elixinol Global Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Elixinol Global Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $85.00K 0.2%
Total Liquid Assets $85.00K 0.20%

Asset Resilience Insights

  • Limited Liquidity: Elixinol Global Ltd maintains only 0.20% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Elixinol Global Ltd Industry Peers by Asset Resilience Ratio

Compare Elixinol Global Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Elixinol Global Ltd (2016–2020)

The table below shows the annual Asset Resilience Ratio data for Elixinol Global Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2020-12-31 0.20% $85.00K $42.47 Million +0.11pp
2019-12-31 0.09% $105.00K $121.07 Million --
2018-12-31 0.00% $0.00 $153.69 Million --
2017-12-31 0.00% $0.00 $105.00 Million --
2016-12-31 0.00% $0.00 $103.81 Million --
pp = percentage points